Ritter Daniher Financial Advisory’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Ritter Daniher Financial Advisory’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20	Closed	-$768	–	316
2024 Q4	$768	Hold	20	–	–	﹤0.01%	299
2024 Q3	$889	Hold	20	–	–	﹤0.01%	299
2024 Q2	$825	Hold	20	–	–	﹤0.01%	295
2024 Q1	$900	Hold	20	–	–	﹤0.01%	288
2023 Q4	$914	Hold	20	–	–	﹤0.01%	328
2023 Q3	$804	Hold	20	–	–	﹤0.01%	333
2023 Q2	$958	Sell	20 -19	-49%	-$950	﹤0.01%	303
2023 Q1	$1.9K	Hold	39	–	–	﹤0.01%	260
2022 Q4	$1.95K	Buy	+39	New	+$2.01K	﹤0.01%	244

Other funds holding GNOM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global ETFs Holdings

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return